Nektar Therapeutics · NASDAQ:NKTR
Nektar Therapeutics shareholders
As of Jun 30, 2026, 229 institutions reported holding Nektar Therapeutics. Largest: Fidelity, Two Seas Capital LP and BlackRock. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Nektar Therapeutics | Change | Filed |
|---|---|---|---|---|
| Fidelity | 5.07M | +765K | Aug 13, 2026 | |
| Two Seas Capital LP | 3.09M | +1.13M | Aug 12, 2026 | |
| BlackRock | 2.94M | +2.25M | Aug 7, 2026 | |
| Bvf Inc | 2.39M | −169K | Aug 14, 2026 | |
| Vanguard | 2.13M | +655K | Aug 13, 2026 | |
| Two Sigma | 1.2M | +271K | Aug 14, 2026 | |
| Vestal Point Capital, LP | 1M | +715K | Aug 14, 2026 | |
| Morgan Stanley | 937K | +277K | Aug 13, 2026 | |
| State Street | 910K | +665K | Aug 7, 2026 | |
| Geode Capital | 881K | +535K | Aug 12, 2026 |